Dr Robert Fredrick Lee Iii, OD | |
15157 Gratiot Ave, Detroit, MI 48205-1324 | |
(313) 526-7664 | |
(313) 526-2055 |
Full Name | Dr Robert Fredrick Lee Iii |
---|---|
Gender | Male |
Speciality | Optometrist |
Location | 15157 Gratiot Ave, Detroit, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013909555 | NPI | - | NPPES |
3289816 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 4901003122 (Michigan) | Primary |
Provider Name | Svs Vision Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1194879023 PECOS PAC ID: 9931257110 Enrollment ID: O20090427000507 |
News Archive
CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.
Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.
Alzheimer's disease affects an estimated 27 million people worldwide. It is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the characteristic changes in the brains of Alzheimer's patients is the accumulation of plaques and tangles; currently, the best hope for curing or at least slowing the disease lies in developing drugs that target this buildup.
During the Forum of the African AIDS Vaccine Program (AAVP) in Kampala, Uganda, on Wednesday, Alan Bernstein, the director of the Global HIV Vaccine Enterprise, discussed ongoing efforts to launch an experimental HIV vaccine trial - similar to the recent trial in Thailand - in Africa, the Daily Monitor reports.
ImThera Medical, Inc. today announced that it has concluded its Phase I and Phase II protocols for the European Pilot study of the aura6000, a neurostimulation device for treating Obstructive Sleep Apnea (OSA). Clinical trial results from the study will be announced at the American Thoracic Society's International Conference on May 16, 2011 in Denver, CO.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Robert Fredrick Lee Iii, OD 15157 Gratiot Ave, Detroit, MI 48205-1324 Ph: (313) 526-7664 | Dr Robert Fredrick Lee Iii, OD 15157 Gratiot Ave, Detroit, MI 48205-1324 Ph: (313) 526-7664 |
News Archive
CPR quality is worse during in-hospital cardiac arrests occurring overnight than those that happen during the day, according to a new University of Pennsylvania School of Medicine study that will be presented at the American Heart Association's annual Scientific Sessions on November 14.
Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.
Alzheimer's disease affects an estimated 27 million people worldwide. It is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the characteristic changes in the brains of Alzheimer's patients is the accumulation of plaques and tangles; currently, the best hope for curing or at least slowing the disease lies in developing drugs that target this buildup.
During the Forum of the African AIDS Vaccine Program (AAVP) in Kampala, Uganda, on Wednesday, Alan Bernstein, the director of the Global HIV Vaccine Enterprise, discussed ongoing efforts to launch an experimental HIV vaccine trial - similar to the recent trial in Thailand - in Africa, the Daily Monitor reports.
ImThera Medical, Inc. today announced that it has concluded its Phase I and Phase II protocols for the European Pilot study of the aura6000, a neurostimulation device for treating Obstructive Sleep Apnea (OSA). Clinical trial results from the study will be announced at the American Thoracic Society's International Conference on May 16, 2011 in Denver, CO.
› Verified 3 days ago
Dr. Sura Hassan, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4717 St. Antoine, Kresge Eye Institute, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 | |
Dr. Richard Edwin Gay, OD Optometrist Medicare: Medicare Enrolled Practice Location: 19173 Mack Ave, Detroit, MI 48230 Phone: 313-882-7883 Fax: 313-882-5128 | |
Heritage Optical Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2678 E Jefferson Ave, Detroit, MI 48207 Phone: 313-259-6006 | |
Dr. Linda Le, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1301 Orleans St Apt 1705, Detroit, MI 48207 Phone: 248-759-9202 | |
Wayne State University Physician Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4717 Saint Antoine St, Detroit, MI 48201 Phone: 313-577-8900 Fax: 313-577-0700 | |
Heritage Optical Center, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 19010 Livernois Ave, Detroit, MI 48221 Phone: 313-863-9581 |